论文信息 - Issue in statistical strategy in case‐control study

Issue in statistical strategy in case‐control study

1. Starlinger P, Assinger A, Haegele S, Wanek D, Zikeli S, Schauer D, et al. Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans. HEPATOLOGY 2014;60:257-266. 2. Lesurtel M, Soll C, Humar B, Clavien PA. Serotonin: a double-edged sword for the liver? Surgeon 2012;10:107-113. 3. Nozaki R, Murata S, Nowatari T, Maruyama T, Ikeda N, Kawasaki T, et al. Effects of thrombopoietin on growth of hepatocellular carcinoma: is thrombopoietin therapy for liver disease safe or not? Hepatol Res 2013;43:610-620. 4. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824-828, discussion 828-829.

[1] O. Farges,et al. The “50-50 Criteria” on Postoperative Day 5: An Accurate Predictor of Liver Failure and Death After Hepatectomy , 2005, Annals of surgery.

[2] H. M. Reis,et al. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma , 2013, Nature Reviews Cancer.

[3] T. Gruenberger,et al. Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans , 2014, Hepatology.

[4] N. Ohkohchi,et al. Effects of thrombopoietin on growth of hepatocellular carcinoma: Is thrombopoietin therapy for liver disease safe or not? , 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

[5] U. Nöthlings,et al. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer , 2014, Hepatology.

[6] Dong-hao Wu,et al. Erratum to: Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma , 2014, Tumor Biology.